Apoptose no carcinoma de próstata

Detalhes bibliográficos
Autor(a) principal: Fermozelli, Ricardo Abeche [UNESP]
Data de Publicação: 2015
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://hdl.handle.net/11449/131884
http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/24-11-2015/000854483.pdf
Resumo: Prostate carcinoma is a frequent cause of morbidity and mortality in Western populations, with high frequency in Brazil. It is the most common cancer among men and the second leading cause of death, preceded by lung cancer. Its incidence has increased continuously in recent decades due to increased life expectancy and the western lifestyle. Apoptosis is a cell death mechanism that occurs in many physiological processes. It is known that tumors show progressive resistance to apoptosis. It is regulated by caspases, apoptosis effector enzymes, whose activation is strictly controlled by Innibitors of Apoptosis Proteins, IAPs, which in turn are modulated by IAP activity inhibitory molecules, with SMAC/Diablo being the main one and the most studied. We studied the relationship between IAPs (XIAP and Survivin) and SMAC in prostatic carcinomas and its correlation with the Apoptotic Index (AI), cellular proliferation, immunohistochemistry expression of protein p53 and patient survival rate. TMA paraffin blocks were made with prostate cancer tissue from patients operated at the Clinics Hospital, Botucatu School of Medicine, from 1980 to 2000. These were submitted to immunohistochemical reaction to Survivin, XIAP, SMAC, p53, cleaved Caspase 3 (apoptotic index) and Ki67 (cell proliferation index). The slides were read by two pathologists, wich graduated the intensity and percentage of positive cells according to immuno-expression of each marker. These results were correlated with the Gleason grade, prognostic categories (ISUP) and patient survival data. A correlation was verified between tumor differentiation and the cell proliferation rate. The intensity of p53 reaction was also associated with the degree of neoplastic differentiation. Patient survival was higher in cases with lower ki67 labelling and lower Gleason and Prognostic Categories grading
id UNSP_d793d38c3b08022955e3357fffa7c869
oai_identifier_str oai:repositorio.unesp.br:11449/131884
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Apoptose no carcinoma de próstataApoptosePróstata - CâncerProteínas - InibidoresPrognosticoApoptosisProstate carcinoma is a frequent cause of morbidity and mortality in Western populations, with high frequency in Brazil. It is the most common cancer among men and the second leading cause of death, preceded by lung cancer. Its incidence has increased continuously in recent decades due to increased life expectancy and the western lifestyle. Apoptosis is a cell death mechanism that occurs in many physiological processes. It is known that tumors show progressive resistance to apoptosis. It is regulated by caspases, apoptosis effector enzymes, whose activation is strictly controlled by Innibitors of Apoptosis Proteins, IAPs, which in turn are modulated by IAP activity inhibitory molecules, with SMAC/Diablo being the main one and the most studied. We studied the relationship between IAPs (XIAP and Survivin) and SMAC in prostatic carcinomas and its correlation with the Apoptotic Index (AI), cellular proliferation, immunohistochemistry expression of protein p53 and patient survival rate. TMA paraffin blocks were made with prostate cancer tissue from patients operated at the Clinics Hospital, Botucatu School of Medicine, from 1980 to 2000. These were submitted to immunohistochemical reaction to Survivin, XIAP, SMAC, p53, cleaved Caspase 3 (apoptotic index) and Ki67 (cell proliferation index). The slides were read by two pathologists, wich graduated the intensity and percentage of positive cells according to immuno-expression of each marker. These results were correlated with the Gleason grade, prognostic categories (ISUP) and patient survival data. A correlation was verified between tumor differentiation and the cell proliferation rate. The intensity of p53 reaction was also associated with the degree of neoplastic differentiation. Patient survival was higher in cases with lower ki67 labelling and lower Gleason and Prognostic Categories gradingO Carcinoma de Próstata é frequente causa de morbi-mortalidade nas populações ocidentais, tendo alta frequência no Brasil. É a neoplasia mais comum do homem, e a segunda causa de óbito, precedido pelo câncer de pulmão. Sua incidência vem aumentando continuamente nas últimas décadas devido ao aumento da perspectiva de vida e ao estilo de vida ocidental. A apoptose é mecanismo de morte celular que ocorre em diversos processos fisiológicos. Sabe-se que neoplasias tem progressiva resistência à apoptose. Esta é regulada pelas caspases, enzimas efetoras da apoptose, cuja ativação é rigorosamente controlada pelas proteínas inibidoras da apoptose, as IAPs, que por sua vez tem atividade modulada por moléculas inibidoras de IAPs, sendo a SMAC/Diablo a principal e a mais estudada. Neste trabalho estudamos a relação entre as IAPs e SMAC nos carcinomas prostáticos e sua correlação com o Índice Apoptótico (IA), proliferação celular, imuno-expressão da proteína p53 e taxa de sobrevida dos pacientes. Foram confeccionados blocos de parafina de TMA com tecido de câncer prostático de pacientes operados no Hospital das Clinicas da Faculdade de Medicina de Botucatu de 1980 a 2000. Estes foram submetidos à reação imuno-histoquímica para Survivina, XIAP, SMAC, p53, Caspase 3 Clivada (índice apoptótico) e Ki67 (índice de proliferação celular). As laminas foram lidas por dois patologistas, sendo obtidas graduações de intensidade de imuno-expressão e/ou percentuais de positividade celular. Esses resultados foram correlacionados com a graduação de Gleason, categorias prognósticas (ISUP) e dados de sobrevida dos pacientes. Houve correlação entre a diferenciação da neoplasia e o índice de proliferação celular. A intensidade da marcação para p53 também esteve associada ao grau de diferenciação neoplásica. A sobrevida dos pacientes foi maior nos casos com menor ki67 e menores Gleason e Categorias PrognósticasUniversidade Estadual Paulista (Unesp)Lima, Flávio de Oliveira [UNESP]Universidade Estadual Paulista (Unesp)Fermozelli, Ricardo Abeche [UNESP]2015-12-10T14:22:23Z2015-12-10T14:22:23Z2015info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis55 f.application/pdfFERMOZELLI, Ricardo Abeche. Apoptose no carcinoma de próstata. 2015. 55 f. Dissertação (mestrado) - Universidade Estadual Paulista Júlio de Mesquita Filho, Faculdade de Medicina, 2015.http://hdl.handle.net/11449/131884000854483http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/24-11-2015/000854483.pdf33004064056P52443296326760741Alephreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPporinfo:eu-repo/semantics/openAccess2024-09-03T19:03:31Zoai:repositorio.unesp.br:11449/131884Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462024-09-03T19:03:31Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Apoptose no carcinoma de próstata
title Apoptose no carcinoma de próstata
spellingShingle Apoptose no carcinoma de próstata
Fermozelli, Ricardo Abeche [UNESP]
Apoptose
Próstata - Câncer
Proteínas - Inibidores
Prognostico
Apoptosis
title_short Apoptose no carcinoma de próstata
title_full Apoptose no carcinoma de próstata
title_fullStr Apoptose no carcinoma de próstata
title_full_unstemmed Apoptose no carcinoma de próstata
title_sort Apoptose no carcinoma de próstata
author Fermozelli, Ricardo Abeche [UNESP]
author_facet Fermozelli, Ricardo Abeche [UNESP]
author_role author
dc.contributor.none.fl_str_mv Lima, Flávio de Oliveira [UNESP]
Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Fermozelli, Ricardo Abeche [UNESP]
dc.subject.por.fl_str_mv Apoptose
Próstata - Câncer
Proteínas - Inibidores
Prognostico
Apoptosis
topic Apoptose
Próstata - Câncer
Proteínas - Inibidores
Prognostico
Apoptosis
description Prostate carcinoma is a frequent cause of morbidity and mortality in Western populations, with high frequency in Brazil. It is the most common cancer among men and the second leading cause of death, preceded by lung cancer. Its incidence has increased continuously in recent decades due to increased life expectancy and the western lifestyle. Apoptosis is a cell death mechanism that occurs in many physiological processes. It is known that tumors show progressive resistance to apoptosis. It is regulated by caspases, apoptosis effector enzymes, whose activation is strictly controlled by Innibitors of Apoptosis Proteins, IAPs, which in turn are modulated by IAP activity inhibitory molecules, with SMAC/Diablo being the main one and the most studied. We studied the relationship between IAPs (XIAP and Survivin) and SMAC in prostatic carcinomas and its correlation with the Apoptotic Index (AI), cellular proliferation, immunohistochemistry expression of protein p53 and patient survival rate. TMA paraffin blocks were made with prostate cancer tissue from patients operated at the Clinics Hospital, Botucatu School of Medicine, from 1980 to 2000. These were submitted to immunohistochemical reaction to Survivin, XIAP, SMAC, p53, cleaved Caspase 3 (apoptotic index) and Ki67 (cell proliferation index). The slides were read by two pathologists, wich graduated the intensity and percentage of positive cells according to immuno-expression of each marker. These results were correlated with the Gleason grade, prognostic categories (ISUP) and patient survival data. A correlation was verified between tumor differentiation and the cell proliferation rate. The intensity of p53 reaction was also associated with the degree of neoplastic differentiation. Patient survival was higher in cases with lower ki67 labelling and lower Gleason and Prognostic Categories grading
publishDate 2015
dc.date.none.fl_str_mv 2015-12-10T14:22:23Z
2015-12-10T14:22:23Z
2015
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv FERMOZELLI, Ricardo Abeche. Apoptose no carcinoma de próstata. 2015. 55 f. Dissertação (mestrado) - Universidade Estadual Paulista Júlio de Mesquita Filho, Faculdade de Medicina, 2015.
http://hdl.handle.net/11449/131884
000854483
http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/24-11-2015/000854483.pdf
33004064056P5
2443296326760741
identifier_str_mv FERMOZELLI, Ricardo Abeche. Apoptose no carcinoma de próstata. 2015. 55 f. Dissertação (mestrado) - Universidade Estadual Paulista Júlio de Mesquita Filho, Faculdade de Medicina, 2015.
000854483
33004064056P5
2443296326760741
url http://hdl.handle.net/11449/131884
http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/24-11-2015/000854483.pdf
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 55 f.
application/pdf
dc.publisher.none.fl_str_mv Universidade Estadual Paulista (Unesp)
publisher.none.fl_str_mv Universidade Estadual Paulista (Unesp)
dc.source.none.fl_str_mv Aleph
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv repositoriounesp@unesp.br
_version_ 1810021356514836480